SAMHD1 and ovarian cancer: The multivariate analysis for breast and NSCLC patients showed that negative SAMHD1 status was the only factor significantly associated with longer DFS (p = 0.005 and p = 0.04, respectively) and a similar trend was observed in ovarian cancer patients (longer DFS associated to SAMHD1 negativity (p = 0.09)) (Supplementary Table S7).